Effects of dark chocolate on azoxymethane-induced colonic aberrant crypt foci

Nutrition and Cancer

Volumn 65, Issue 5, 2013, Pages 677-685

  Hong, Mee Young ^a   Nulton, Emily ^a   Shelechi, Mahshid ^a   Hernández, Lisa M ^a   Nemoseck, Tricia ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; CYCLOOXYGENASE 2; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CACAO; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DIET; DOWN REGULATION; GENE EXPRESSION; INFLAMMATION; MALE; NONHUMAN; RAT;

ABERRANT CRYPT FOCI; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; AZOXYMETHANE; CACAO; CANDY; CARCINOGENS; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; DOWN-REGULATION; MALE; PLANT EXTRACTS; POLYPHENOLS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION FACTOR RELA;

EID: 84880396123     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2013.789542     Document Type: Article

References (60)

1. Cancer facts and figures 2012. (2012). Retrieved from www.cancer.org
2. Frieden TR, Myers JE, Krauskopf MS, and Farley TA: A public health approach to winning the war against cancer. Oncologist 13, 1306-1313, 2008.
3. Fontham ET, Thun MJ, Ward E, Portier KM, Balch AJ, et al.: ACS Cancer and the Environment Subcommittee: American Cancer Society perspectives on environmental factors and cancer. CA Cancer J Clin 59, 343-351, 2009.
4. Bobe G, Sansbury LB, Albert PS, Cross AJ, Kahle L, et al.: Dietary flavonoids and colorectal adenoma recurrence in the polyp prevention trial. Cancer Epidemio Biomarkers Prev 17, 1344-1353, 2008.
5. Carnesecchi S, Schneider Y, Lazarus SA, Coehlo D, Gosse F, et al.: Flavanols and procyanidins of cocoa and chocolate inhibit growth and polyamine biosynthesis of human colonic cancer cells. Cancer Lett 175, 147-155, 2002.
6. Weisburger JH: Chemopreventive effects of cocoa polyphenols on chronic diseases. Exp Biol Med 226, 891-897, 2001.
7. Kahle K, Kraus M, Scheppach W, and Richling E: Colonic availability of apple polyphenols: a study in ileostomy subjects. Mol Nutr Food Res 49, 1143-1150, 2005.
8. Stingl JC, Ettrich T, MucheR,Wiedom M, Brockmoller J, et al.: Protocol for Minimizing the Risk of Metachronous Adenomas of the Colorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention ofmetachronous colon adenomas in the elderly population. BMC Cancer 11, 360, 2011.
9. Traustadottir T, Davies SS, Stock AA, Su Y, Heward CB, et al.: Tart cherry juice decreases oxidative stress in healthy older men and women. J Nutr 139, 1896-1900, 2009.
10. Hoensch HP and Oertel R: Emerging role of bioflavonoids in gastroenterology: Especially their effects on intestinal neoplasia. World J Gastrointest Oncol 3, 71-74, 2011.
11. Miller KB, Stuart DA, Smith NL, Lee CY, McHale NL, et al.: Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem 54, 4062-4068, 2006.
12. Vinson JA, Proch J, Bose P, Muchler S, Taffera P, et al.: Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets. J Agric Food Chem 54, 8071-8076, 2006.
13. Keen CL, Holt RR, Oteiza PI, Fraga CG, and Schmitz HH: Cocoa antioxidants and cardiovascular health. Am J Clin Nutr 81, 298S-303S, 2005.
14. Spadafranca A,Martinez Conesa C, Sirini S, and Testolin G: Effect of dark chocolate on plasma epicatechin levels, DNA resistance to oxidative stress and total antioxidant activity in healthy subjects. Br J Nutr 103, 1008-1014, 2009.
15. Rein D, Lotito S, Holt RR, Keen CL, Schmitz HH, et al.: Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. J Nutr 130(8S Suppl), 2109S-2114S, 2000.
16. Carnesecchi S, Schneider Y, Lazarus SA, Coehlo D, Gosse F, et al.: Flavanols and procyanidins of cocoa and chocolate inhibit growth and polyamine biosynthesis of human colonic cancer cells. Cancer Lett 175, 147-155, 2002.
17. Maskarinec G: Cancer protective properties of cocoa: a review of the epidemiologic evidence. Nutr Cancer 61, 573-579, 2005.
18. Oleaga C, Garcia M, Sole A, Ciudad CJ, Izquierdo-Pulido M, et al.: CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract. Eur J Nutr 51, 465-476, 2011.
19. Preza AM, Jaramillo ME, Puebla AM, Mateos JC, Hernandez R, et al.: Antitumor activity against murine lymphoma L5178Y model of proteins from cacao (Theobroma cacao L.) seeds in relation with in vitro antioxidant activity. BMC Complement Altern Med 10, 61, 2010.
20. ArlorioM, Bottini C, Travaglia F, Locatelli M, BordigaM, et al.: Protective activity of Theobroma cacao L. phenolic extract on AML12 and MLP29 liver cells by preventing apoptosis and inducing autophagy. J Agric Food Chem 57, 10612-10618, 2009.
21. Ohno M, Sakamoto KQ, Ishizuka M, and Fujita S: Crude cacao Theobroma cacao extract reduces mutagenicity induced by benzo[a]pyrene through inhibition of CYP1A activity in vitro. Phytother Res 23, 1134-1139, 2009.
22. Bisson JF, Guardia-Llorens MA, Hidalgo S, Rozan P, and Messaoudi M: Protective effect of Acticoa powder, a cocoa polyphenolic extract, on prostate carcinogenesis in Wistar-Unilever rats. Eur J Cancer Prev 17, 54-61, 2008.
23. Erlejman AG, Fraga CG, and Oteiza PI: Procyanidins protect Caco-2 cells from bile acid-and oxidant-induced damage. Free Radic Biol Med 41, 1247-1256, 2006.
24. Jourdain C, Tenca G, Deguercy A, Troplin P, and Poelman D: In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells. Eur J Cancer Prev 15, 353-361, 2006.
25. Noe V, Penuelas S, Lamuela-Raventos RM, Permanyer J, Ciudad CJ, and Izquierdo-Pulido M: Epicatechin and a cocoa polyphenolic extract modulate gene expression in human Caco-2 cells. J Nutr 134, 2509-2516, 2004.
26. Ali A, Selamat J, Man YB, and Suria AM: Characterization and fat migration of palm kernel stearin as affected by addition of desiccated coconut used as base filling centre in dark chocolate. Int J Food Sci Nutr 52, 251-261, 2001.
27. Jinap S, Ali AA, Man YB, and Suria AM: Use of palm mid-fraction in dark chocolate as base filling centre at different storage temperatures. Int J Food Sci Nutr 15, 489-499, 2000.
28. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, et al.: Lipophilic and hydrophilic antioxidant capacities of common foods in the United States. J Agric Food Chem 52, 4026-4037, 2004.
29. Gu L, House SE,Wu X, Ou B, Prior RL: Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem 54, 4057-1061, 2006.
30. Warren CA, Paulhill KJ, Davidson LA, Lupton JR, Taddeo SS, et al.: Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. J Nutr 139, 101-105, 2009.
31. Hong MY, Chang WCL, Chapkin RS, and Lupton JR: Relationship among colonocyte proliferation, differentiation and apoptosis as a function of diet and carcinogen. Nutr Cancer 28, 20-29, 1997.
32. Hong MY, Chapkin RS, Wild CP, Morris JS, Wang N, et al.: Relationship between DNA adduct levels, repair enzyme and apoptosis as a function of DNA methylation by azoxymethane. Cell Growth Differ 10, 749-758, 1999.
33. Hong MY, Bancroft LK, Turner ND, Davidson LA, Murphy ME, et al.: Fish oil decreases oxidative DNA damage by enhancing apoptosis in rat colon. Nutr Cancer 52, 166-175, 2005.
34. Hong MY, Turner ND, Carroll RJ, Chapkin RS, and Lupton JR: Differential response to DNA damage may explain different cancer susceptibility between small and large intestine. Exp BiolMed (Maywood) 230, 464-471, 2005.
35. Hong MY, Henning S, Moro A, Seeram NP, Zhang Y, et al.: Chinese red yeast rice inhibition of prostate tumor growth in SCID mice. Cancer Prev Res 4, 608-615, 2011.
36. AnderssonD, Cheng Y, andDuan RD: Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats. J Cancer Res Clin Oncol 134, 101-107, 2008.
37. Challa A, Rao DR, and Reddy BS: Interactive suppression of aberrant crypt foci induced by azoxymethane in rat colon by phytic acid and green tea. Carcinogenesis 18, 2023-2026, 1997.
38. SengottuvelanMand Nalini N: Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazone-treated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br J Nutr 96, 145-153, 2006.
39. Yamagishi M, Natsume M, Osakabe N, Nakamura H, Furukawa F, et al.: Effects of cacao liquor proanthocyanidins on PhIP-induced mutagenesis in vitro, and in vivo mammary and pancreatic tumorigenesis in female Sprague-Dawley rats. Cancer Lett 185,123-130, 2002.
40. Kraus S and Arber N: Inflammation and colorectal cancer. Curr Opin Pharmacol 9, 405-410, 2009.
41. Conner EMand GrishamMB: Inflammation, free radicals, and antioxidants. Nutrition 12, 274-277, 1996.
42. Rodriguez-Ramiro I, Ramos S, Lopez-Oliva E, Agis-Torres A, Gomez- Juaristi M, et al.: Cocoa-rich diet prevents azoxymethane-induced colonic preneoplastic lesions in rats by restraining oxidative stress and cell proliferation and inducing apoptosis. Mol Nutr Food Res 55, 1895-1899, 2011.
43. Charalambous MP, Lightfoot T, Speirs V, Horgan K, and Gooderham NJ: Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue. Br J Cancer 10, 106-115, 2009.
44. Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, et al.: Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 15, 2248-2258, 2009.
45. Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, et al.: Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res 24, 675-681, 2004.
46. Puvvada SD, Funkhouser WK, Greene K, Deal A, Chu H, et al.: NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer. Oncology 78, 181-188, 2010.
47. Fournier DB and Gordon GB: COX-2 and colon cancer: potential targets for chemoprevention. J Cell Biochem Suppl 34, 97-102, 2000.
48. Wang D and Dubois RN: The role of COX-2 in intestinal inflammation and colorectal cancer. Oncogene 29, 781-788, 2010.
49. Mariani F, Sena P,Marzona L, Riccio M, Fano R, et al.: Cyclooxygenase-2 and hypoxia-inducible factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett 279, 221-229, 2009.
50. Duque J, Diaz-Munoz MD, Fresno M, and Iniguez MA: Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells. Cell Signal 18, 1262-1269, 2006.
51. Vaish Vand Sanyal SN: Chemopreventive effects of NSAIDs on cytokines and transcription factors during the early stages of colorectal cancer. Pharmacol Rep 63, 1210-1221, 2011.
52. Stack E and DuBois RN: Role of cyclooxygenase inhibitors for the prevention of colorectal cancer. Gastroenterol Clin North Am 30, 1001-1010, 2001.
53. Ding EL, Hutfless SM, Ding X, and Girotra S: Chocolate and prevention of cardiovascular disease: a systematic review. Nut Metab 3, 2-13, 2006.
54. Schramm DD,Wang JF, Holt RR, Ensunsa JL, Gonsalves JL, et al.: Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 73, 36-40, 2001.
55. Bouayed J and Bohn T: Exogenous antioxidants: double-edged swords in cellular redox state. Health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 3, 228-237, 2010.
56. Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, et al.: Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett 208, 155-161, 2004.
57. Hong MY, Chapkin RS, Morris JS, Wang N, Carroll RJ, et al.: Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis 22, 1831-1835, 2001.
58. Kinjo T, Suzui M, Morioka T, Inamine M, Kaneshiro T, et al.: Reduced expression level of mgmt mRNA and beta-catenin gene mutation in rat colon tumors. Anticancer Res 26, 2829-2832, 2006.
59. Lodovici M, CasaliniC,De Filippo C, Copeland E,XuX, et al.: Inhibition of 1,2-dimethylhydrazine-induced oxidativeDNAdamage in rat colonmucosa by black tea complex polyphenols. Food Chem Toxicol 38, 1085-1088, 2000.
60. Bancroft LK, Lupton JR, Davidson LA, Taddeo SS, Murphy ME, et al.: Dietary fish oil reduces oxidative DNA damage in rat colonocytes. Free Radic Biol Med 35, 149-159, 2003.